Cargando…

Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent

Two rapid real-time RT-PCR assays, specific for respiratory syncytial virus (RSV) and influenza A and B, were evaluated for the detection of these viruses in clinical respiratory samples. The RSV assay was applied to 100 samples and the Influenza A and B assay applied to 96 samples all of which had...

Descripción completa

Detalles Bibliográficos
Autores principales: Sails, Andrew D., Saunders, David, Airs, Stephanie, Roberts, David, Eltringham, Gary, Magee, John G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119759/
https://www.ncbi.nlm.nih.gov/pubmed/19651159
http://dx.doi.org/10.1016/j.jviromet.2009.07.020
_version_ 1783514829596655616
author Sails, Andrew D.
Saunders, David
Airs, Stephanie
Roberts, David
Eltringham, Gary
Magee, John G.
author_facet Sails, Andrew D.
Saunders, David
Airs, Stephanie
Roberts, David
Eltringham, Gary
Magee, John G.
author_sort Sails, Andrew D.
collection PubMed
description Two rapid real-time RT-PCR assays, specific for respiratory syncytial virus (RSV) and influenza A and B, were evaluated for the detection of these viruses in clinical respiratory samples. The RSV assay was applied to 100 samples and the Influenza A and B assay applied to 96 samples all of which had been tested previously by an “in-house” multiplex real-time PCR assay. Forty-three samples were negative for RSV by both methods and 56 samples were positive by both methods. One sample was negative by the new RSV assay although it was positive for RSV A by the “in-house” test. Thirty-nine samples were negative for influenza virus by both methods and 55 samples were positive by both assays. Two samples were negative by the new influenza assay however they were positive by the “in-house” influenza assay. The new assays did not cross react with samples containing other viruses including parainfluenza 1, 2, and 4; human metapnuemovirus; coronavirus 229E, NL63, OC43; rhinovirus; adenovirus; bocavirus and had a specificity of 100% and a sensitivity of 98.2% for RSV and 96.5% for influenza respectively. The results of this study demonstrate that the new assays are specific and sensitive for the detection of RSV and influenza viruses in clinical samples.
format Online
Article
Text
id pubmed-7119759
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71197592020-04-08 Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent Sails, Andrew D. Saunders, David Airs, Stephanie Roberts, David Eltringham, Gary Magee, John G. J Virol Methods Article Two rapid real-time RT-PCR assays, specific for respiratory syncytial virus (RSV) and influenza A and B, were evaluated for the detection of these viruses in clinical respiratory samples. The RSV assay was applied to 100 samples and the Influenza A and B assay applied to 96 samples all of which had been tested previously by an “in-house” multiplex real-time PCR assay. Forty-three samples were negative for RSV by both methods and 56 samples were positive by both methods. One sample was negative by the new RSV assay although it was positive for RSV A by the “in-house” test. Thirty-nine samples were negative for influenza virus by both methods and 55 samples were positive by both assays. Two samples were negative by the new influenza assay however they were positive by the “in-house” influenza assay. The new assays did not cross react with samples containing other viruses including parainfluenza 1, 2, and 4; human metapnuemovirus; coronavirus 229E, NL63, OC43; rhinovirus; adenovirus; bocavirus and had a specificity of 100% and a sensitivity of 98.2% for RSV and 96.5% for influenza respectively. The results of this study demonstrate that the new assays are specific and sensitive for the detection of RSV and influenza viruses in clinical samples. Elsevier B.V. 2009-12 2009-08-03 /pmc/articles/PMC7119759/ /pubmed/19651159 http://dx.doi.org/10.1016/j.jviromet.2009.07.020 Text en Copyright © 2009 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sails, Andrew D.
Saunders, David
Airs, Stephanie
Roberts, David
Eltringham, Gary
Magee, John G.
Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent
title Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent
title_full Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent
title_fullStr Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent
title_full_unstemmed Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent
title_short Evaluation of the Cepheid Respiratory Syncytial Virus and Influenza Virus A/B real-time PCR analyte specific reagent
title_sort evaluation of the cepheid respiratory syncytial virus and influenza virus a/b real-time pcr analyte specific reagent
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119759/
https://www.ncbi.nlm.nih.gov/pubmed/19651159
http://dx.doi.org/10.1016/j.jviromet.2009.07.020
work_keys_str_mv AT sailsandrewd evaluationofthecepheidrespiratorysyncytialvirusandinfluenzavirusabrealtimepcranalytespecificreagent
AT saundersdavid evaluationofthecepheidrespiratorysyncytialvirusandinfluenzavirusabrealtimepcranalytespecificreagent
AT airsstephanie evaluationofthecepheidrespiratorysyncytialvirusandinfluenzavirusabrealtimepcranalytespecificreagent
AT robertsdavid evaluationofthecepheidrespiratorysyncytialvirusandinfluenzavirusabrealtimepcranalytespecificreagent
AT eltringhamgary evaluationofthecepheidrespiratorysyncytialvirusandinfluenzavirusabrealtimepcranalytespecificreagent
AT mageejohng evaluationofthecepheidrespiratorysyncytialvirusandinfluenzavirusabrealtimepcranalytespecificreagent